World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 16 March 2021
Main ID:  ACTRN12614001276640
Date of registration: 05/12/2014
Prospective Registration: Yes
Primary sponsor: Christine Imms
Public title: Minimising impairment: A multicentre randomized controlled trial of upper limb orthoses for children with cerebral palsy.
Scientific title: Does wearing a rigid upper limb wrist hand orthosis in combination with evidence informed occupational therapy, compared to evidence informed occupational therapy alone, reduce wrist/hand impairment and improve activity and participation outcomes in children aged 5-15 years with cerebral palsy?
Date of first enrolment: 28/08/2015
Target sample size: 194
Recruitment status: Stopped early
URL:  https://anzctr.org.au/ACTRN12614001276640.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Prof Christine Imms   
Address:  University of Melbourne Department of Paediatrics | MDHS Level 3, West Building, Royal Children’s Hospital 50 Flemington Road, Parkville, Victoria 3052 Australia Australia
Telephone: +61393454953
Email: christine.imms@unimelb.edu.au
Affiliation: 
Name: Prof Christine Imms   
Address:  University of Melbourne Department of Paediatrics | MDHS Level 3, West Building, Royal Children’s Hospital 50 Flemington Road, Parkville, Victoria 3052 Australia Australia
Telephone: +61393454953
Email: christine.imms@unimelb.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: A confirmed diagnosis of cerebral palsy as recorded in the medical history;
Aged 5-15 years;
Presence of flexor muscle stiffness - score at least 1 on the Modified Ashworth Scale during wrist extension with fingers extended;
May or may not already exhibit contracture at the wrist.

Exclusion criteria: Dystonic, rather than spastic, motor disorder;
Allergy/sensitivity to splinting material;
Upper limb surgery during the study period or in the 12 months preceding study commencement;
Significant child refusal to comply with splint wearing schedule;
Family inability to access the study assessment or treatment site (due to geography).


Age minimum: 5 Years
Age maximum: 15 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Children with cerebral palsy;
Children with cerebral palsy
Neurological - Other neurological disorders
Intervention(s)
The treatment group will receive a custom-made serially adjustable rigid wrist/hand orthosis (WHO) to maintain the flexor compartment (muscles of the wrist, fingers and thumb) in a lengthened position to avoid shortening of the musculo-tendinous unit and other soft tissue.
Children will be asked to wear the splint overnight, or for a minimum of 6 hours during the night or day (nightly/daily), for the three years of the study, to achieve a prolonged positioning effect with the orthosis. Although night time wear is recommended, for some children it may be appropriate to wear the orthosis during the day.
An App (iPhone and android compatible) will be used to monitor factors such as the use of orthoses and any adverse events, based on parent report. Parents will receive a weekly text-reminder to record therapy received in the past week using simple response formats.
Data recorded on the App will be supplemented through a 6-monthly parent interview conducted by the site based research assistant to record additional details about the usual evidence-informed therapy their child received in the preceding period.
All children (regardless of group allocation) will receive care typically provided by their usual treating organisation. Possible treatments may include developmentally appropriate, goal focused and evidence-informed occupational therapy, the use of equipment or BoNT-A injections.
Primary Outcome(s)
Passive range of passive wrist extension (measured with the fingers extended) measured using a goniometer[3 Years]
Active range of wrist movement measured using standardised goniometric measurement and use of clinometer for measures of supination and inertial motion sensors [3 Years]
Secondary Outcome(s)
Quality of life outcomes measured using:
Quality of life: Cerebral Palsy Quality of Life Questionnaire - Child and Teen versions (Waters et al. 2007; Davis et al. 2013)
Assessing quality of life AQoL-8D - multi-attribute utility instrument (Richardson et al. 2014)[3 years ]
Body function outcomes:
Grip Strength measured using hand held dynamometer Merlini et al. 2002);[3 Years]
Body function outcomes:
Hand deformity measured using the Neurological Hand Deformity Classification (Wilton 2004);[3 Years]
Relative cost and cost effectiveness measured using pathway analysis to document treatment activity, specify unit prices and estimate costs and potential cost offsets across the arms of the trial. Costs will be assessed by expenditure category (salaries; capital; overheads; consumables; etc.) as well as incidence (i.e. who bears the cost).[3 years ]
Body function outcomes:
Muscle spasticity (finger flexors, wrist extensors, pronators and elbow flexors), measured using Modified Tardieu Scale;[3 Years]
Body function measures:
Pain measured using a study specific questionnaire[3 years ]
Activity level outcomes:
Manual Ability measured using ABILHAND-Kids (Arnould, et al. 2004);
[3 years]
Activity level outcomes:
Self care skills measured using the Pediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT; Haley, et al. 2011);
[3 years]
Activity level outcomes:
Speed and dexterity measured using Box and Blocks Test (Mathiowetz et al. 1985);
[3 years]
Body function outcomes:
Muscle tone (finger flexors, wrist extensors, pronators and elbow flexors) measured using Modified Ashworth Scale (Boyd et al, 1999);[3 Years]
Participation outcomes:
measured using the Participation and Environment Measure for Children and Youth (PEM-CY; Coster et al. 2011)
[3 years ]
Activity level outcomes:
Ease of care measured using a study specific questionnaire.
[3 years ]
Activity level outcomes:
Hand function measured using the Modified House Scale (Geerdink et al. 2014);
[3 years]
Secondary ID(s)
none
Source(s) of Monetary Support
Australian Catholic University
National Health and Medical Research Centre, Australia
Secondary Sponsor(s)
Brian Hoare
Catherine Elliott
Margaret Wallen
Susan Greaves
Ethics review
Status: Approved
Approval date: 04/09/2014
Contact:
The Cerebral Palsy Alliance
Status: Approved
Approval date: 09/10/2014
Contact:
Monash Medical Centre
Status: Approved
Approval date: 24/11/2014
Contact:
Australian Catholic University
Status: Approved
Approval date: 25/11/2014
Contact:
Perth Children's Hospital
Status: Approved
Approval date: 08/05/2015
Contact:
The Royal Children's Hospital Melbourne
Results
Results available: Yes
Date Posted: 18/07/2019
Date Completed: 20/12/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history